Liposomal irinotecan in patients with HER2-negative breast cancer and brain metastases: The PHENOMENAL phase 2 study.

Borrego MR, López-Bravo DP, Vila MM, Pérez-García JM, Fernández M, Tormo SB, García-Saenz JÁ, Lema L, Garau I, Cortez P, Torres AA, Conejo EA, Calvo I, Ferrer N, Blancas I, Amillano K, Santasusagna S, Benderra MA, Alcalá-López D, Antonarelli G, Sampayo-Cordero M, Llombart-Cussac A, Cortés J

Open source

DOI: 10.1016/j.ejca.2025.116161
Published: 2026 Jan 17
Container: European journal of cancer (Oxford, England : 1990)
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.ejca.2025.116161,
  title = {Liposomal irinotecan in patients with HER2-negative breast cancer and brain metastases: The PHENOMENAL phase 2 study.},
  author = {Borrego MR and López-Bravo DP and Vila MM and Pérez-García JM and Fernández M and Tormo SB and García-Saenz JÁ and Lema L and Garau I and Cortez P and Torres AA and Conejo EA and Calvo I and Ferrer N and Blancas I and Amillano K and Santasusagna S and Benderra MA and Alcalá-López D and Antonarelli G and Sampayo-Cordero M and Llombart-Cussac A and Cortés J},
  year = {2026},
  journal = {European journal of cancer (Oxford, England : 1990)},
  doi = {10.1016/j.ejca.2025.116161},
  url = {https://doi.org/10.1016/j.ejca.2025.116161}
}

RIS

TY  - JOUR
TI  - Liposomal irinotecan in patients with HER2-negative breast cancer and brain metastases: The PHENOMENAL phase 2 study.
AU  - Borrego MR
AU  - López-Bravo DP
AU  - Vila MM
AU  - Pérez-García JM
AU  - Fernández M
AU  - Tormo SB
AU  - García-Saenz JÁ
AU  - Lema L
AU  - Garau I
AU  - Cortez P
AU  - Torres AA
AU  - Conejo EA
AU  - Calvo I
AU  - Ferrer N
AU  - Blancas I
AU  - Amillano K
AU  - Santasusagna S
AU  - Benderra MA
AU  - Alcalá-López D
AU  - Antonarelli G
AU  - Sampayo-Cordero M
AU  - Llombart-Cussac A
AU  - Cortés J
PY  - 2026
JO  - European journal of cancer (Oxford, England : 1990)
DO  - 10.1016/j.ejca.2025.116161
UR  - https://doi.org/10.1016/j.ejca.2025.116161
ER  -

APA

MR, B., DP, L., MM, V., JM, P., M, F., SB, T., JÁ, G., L, L., I, G., P, C., AA, T., EA, C., I, C., N, F., I, B., K, A., S, S., MA, B., D, A., G, A., M, S., A, L., & J, C. (2026). Liposomal irinotecan in patients with HER2-negative breast cancer and brain metastases: The PHENOMENAL phase 2 study.. European journal of cancer (Oxford, England : 1990). https://doi.org/10.1016/j.ejca.2025.116161

Source records

pubmed · retrieved 2026-09-27T01:16:25.951Z